Botulism Therapeutics Market to Witness Upsurge in Growth During the Study Period [2018-2030] | Key Companies Includes Ology Bioservices, DynPort, AlphaVax, PanThera Biopharma, and Others

5353 Delveinsight


DelveInsight’s Botulism Market Insights Report offers a detailed analysis of disease, its causes, symptoms, diagnostics modalities, and treatment options. The report also offers comprehensive insights into Botulism market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing clinical trials, key collaboration in the space, and key pharmaceutical companies actively pushing the growth of market size forward. 

Some of the key highlights from the Botulism Market Insights: 

  • According to the Centers for Disease Control and Prevention (CDC), about 145 cases of botulism are reported every year in the United States. About 3 to 5 percent of those with botulism poisoning die. 
  • There are three main types of botulism namely infant botulism, foodborne botulism, and wound botulism. In the United States, nearly 65 percent of botulism cases occur in infants or children younger than 1 year of age. Around 15 percent of botulism cases are foodborne.
  • The Botulism Therapeutics Market is limited and consists of early phase assets. The key players such as AlphaVax, Merz Therapeutics, Ology Bioservices, DynPort, PanThera Biopharma, and others are involved in the development of therapies for Botulism.
  • Some of the key Botulism therapies that are under-development stage include NTM 1631 (formerly known as XOMA 3AB), Biodefence vaccines, Anti-infectives, Botulinum toxin vaccine, and several others. The Botulism therapies are anticipated to launch in the coming years and are expected to improve the treatment outcome for the affected people.  
  • As per DelveInsight, owing to the R&D activity and the increased incidence, the Botulism Market is expected to grow in the coming years. 

Learn more by requesting for sample @ Botulism Market Landscape 

Botulism: Overview 

Botulism (or botulism poisoning) is a rare but very serious illness caused by a nerve toxin produced by the bacterium Clostridium botulinum. There are three main types of botulism: infant botulism, foodborne botulism, and wound botulism. According to the National Botulism Surveillance Summary (2017), 182 laboratory-confirmed botulism cases were reported to CDC in 2017. The toxin may enter the body depending on the type of exposure. It can transmit through food, contact with contaminated soil, or through an open wound. Botulism is diagnosed based on the clinical history and clinical examination followed by laboratory confirmation. A delay in treatment can lead to paralysis, breathing difficulties, and even death.

For more insights into Disease, causes, and treatment, reach out @ Botulism Treatment Landscape 

Botulism Epidemiology Segmentation

The Botulism Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:

  • Total Incident cases of Botulism 
  • Cases of Botulism by Toxin Type
  • Diagnosed and Treatable cases of Botulism
  • Cases of Botulism by transmission category

Visit for more @ Botulism Epidemiological Insights 

Botulism Market

The current treatment of Botulism includes Antitoxin which is administered as soon as possible after a clinical diagnosis. Early diagnosis and treatment are effective in reducing mortality rates. Severe botulism cases require supportive treatment, especially mechanical ventilation, which may be required for weeks or even months. In the case of wound botulism, the treatment approach includes antitoxin administration, hospital admission, close monitoring, respiratory support. 

The vaccine is available in the market but has some negative side effects. To overcome the existing unmet need and to provide effective therapeutics options, several companies are working to develop new therapies based on different MoA to treat Botulism. Currently, the Botulism therapeutics market is limited and consists of early Phase assets.

Botulism Pipeline Therapies and Key Companies

  • NTM 1631 (formerly known as XOMA 3AB) – Ology Bioservices
  • Botulinum toxin vaccine – DynPort Vaccine Company LLC
  • Biodefence vaccines (Research program) – AlphaVax, Inc.
  • Anti-infectives (Research programme) – PanThera Biopharma

For more information, visit: Botulism Market Analysis, Patient Pool, and Emerging Therapies 

Botulism Market Drivers 

  • Rising Incidence
  • Launch of the Emerging Therapies
  • Ongoing R&D Activities in the Domain

Scope of the Report

  • 11 Years Forecast
  • 7MM Coverage 
  • Descriptive overview of Botulism, covering causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
  • Comprehensive insight into Botulism epidemiology and treatment in the 7MM
  • Current and emerging therapies for Botulism 
  • Botulism market drivers and barriers 

Key Questions Answered in the Report

  • What was the Botulism market share (%) distribution in 2017 and how it would look like in 2030?
  • What would be the Botulism total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Botulism market size during the forecast period (2017-2030)?
  • At what CAGR, the Botulism market is expected to grow in the 7MM during the forecast period (2017-2030)?

Get in touch with our Business executive @ Botulism Market Landscape Analysis 

Table of Contents 


Key Insights


Report Introduction


Competitive Intelligence Analysis for Botulism


Botulism Market Overview at a Glance


Executive Summary of Botulism


Botulism Epidemiology and Market Methodology


Botulism Epidemiology and Patient Population


Botulism Patient Journey


Treatment Algorithm, Current Treatment, and Medical Practices


Key Endpoints in Botulism Clinical Trials


Botulism Marketed Therapies 


Botulism Emerging Therapies


Botulism: 7 Major Market Analysis


Attribute analysis


Access and Reimbursement Overview of Botulism


KOL Reviews


Case Reports


Botulism Market Drivers


Botulism Market Barriers


SWOT Analysis




DelveInsight Capabilities


About DelveInsight

Learn more about the report offerings @ Botulism Market Outlook

Related Reports

Botulism Pipeline Insights
Botulism Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Botulism market.

Meniere’s Disease Market
DelveInsight’s “Meniere’s Disease Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Meniere’s Disease market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Pars Plantis Market
DelveInsight’s “Pars Plantis Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Pars Plantis market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Nicotine Addiction Market
DelveInsight’s “Nicotine Addiction Market Insights, Epidemiology and Market Forecast 2030” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Nicotine Addiction market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Advanced Wound Care (AWC) Market
DelveInsight’s ‘Advanced Wound Care (AWC) Market Insights, Competitive Landscape, and Market Forecast-2026’ report deliver an in-depth understanding of advanced wound care and the historical and forecasted Advanced Wound Care Market Trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Healthcare Blogs

Get in touch with our Business executive for Competitive Intelligence Services

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect With Us at LinkedIn | Facebook | Twitter

Tags: Botulism Pipeline, Botulism, Botulism – Market, Botulism Treatment, Botulism Epidemiology, Botulism Therapies

See Campaign:
Contact Information:
Shruti Thakur  +91-9650213330

Menafn, IPS, Reportedtimes, PR-Wirein, iCN Internal Distribution, Extended Distribution, Research Newswire, English

Contact Information:

Shruti Thakur  +91-9650213330